nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.235	1	CbGaD
Quetiapine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0916	0.208	CbGbCtD
Quetiapine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0586	0.133	CbGbCtD
Quetiapine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0509	0.116	CbGbCtD
Quetiapine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.047	0.107	CbGbCtD
Quetiapine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0253	0.0575	CbGbCtD
Quetiapine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0253	0.0575	CbGbCtD
Quetiapine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0192	0.0437	CbGbCtD
Quetiapine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0192	0.0437	CbGbCtD
Quetiapine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0171	0.0389	CbGbCtD
Quetiapine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0161	0.0367	CbGbCtD
Quetiapine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0109	0.0248	CbGbCtD
Quetiapine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0106	0.0241	CbGbCtD
Quetiapine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0104	0.0236	CbGbCtD
Quetiapine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00926	0.0211	CbGbCtD
Quetiapine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00907	0.0206	CbGbCtD
Quetiapine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00856	0.0195	CbGbCtD
Quetiapine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00612	0.202	CbGeAlD
Quetiapine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00543	0.0124	CbGbCtD
Quetiapine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00513	0.0117	CbGbCtD
Quetiapine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00356	0.118	CbGeAlD
Quetiapine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00222	0.0735	CbGeAlD
Quetiapine—H1F0—respiratory system—chronic obstructive pulmonary disease	0.000971	0.0321	CbGeAlD
Quetiapine—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.000926	0.0306	CbGeAlD
Quetiapine—H1F0—connective tissue—chronic obstructive pulmonary disease	0.000855	0.0283	CbGeAlD
Quetiapine—H1F0—bronchus—chronic obstructive pulmonary disease	0.000799	0.0264	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—chronic obstructive pulmonary disease	0.000782	0.0259	CbGeAlD
Quetiapine—H1F0—trachea—chronic obstructive pulmonary disease	0.000717	0.0237	CbGeAlD
Quetiapine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000662	0.0219	CbGeAlD
Quetiapine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000599	0.0198	CbGeAlD
Quetiapine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000566	0.0187	CbGeAlD
Quetiapine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000527	0.0174	CbGeAlD
Quetiapine—CHRM1—trachea—chronic obstructive pulmonary disease	0.00052	0.0172	CbGeAlD
Quetiapine—H1F0—lung—chronic obstructive pulmonary disease	0.000515	0.0171	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000507	0.0168	CbGeAlD
Quetiapine—HTR3A—lung—chronic obstructive pulmonary disease	0.000492	0.0163	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000482	0.016	CbGeAlD
Quetiapine—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000461	0.0152	CbGeAlD
Quetiapine—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000453	0.015	CbGeAlD
Quetiapine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000447	0.0148	CbGeAlD
Quetiapine—HTR7—trachea—chronic obstructive pulmonary disease	0.000443	0.0146	CbGeAlD
Quetiapine—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000407	0.0135	CbGeAlD
Quetiapine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000394	0.013	CbGeAlD
Quetiapine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000387	0.0128	CbGeAlD
Quetiapine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000374	0.0124	CbGeAlD
Quetiapine—CHRM1—lung—chronic obstructive pulmonary disease	0.000373	0.0124	CbGeAlD
Quetiapine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000362	0.012	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00036	0.0119	CbGeAlD
Quetiapine—HRH1—trachea—chronic obstructive pulmonary disease	0.000331	0.0109	CbGeAlD
Quetiapine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000329	0.0109	CbGeAlD
Quetiapine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000325	0.0107	CbGeAlD
Quetiapine—Flupentixol—HTR2A—chronic obstructive pulmonary disease	0.000319	0.0671	CrCbGaD
Quetiapine—HTR7—lung—chronic obstructive pulmonary disease	0.000318	0.0105	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000301	0.00995	CbGeAlD
Quetiapine—DRD2—lung—chronic obstructive pulmonary disease	0.000301	0.00995	CbGeAlD
Quetiapine—ADRA2C—lung—chronic obstructive pulmonary disease	0.000292	0.00967	CbGeAlD
Quetiapine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000276	0.00913	CbGeAlD
Quetiapine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000245	0.0081	CbGeAlD
Quetiapine—CYP3A5—lung—chronic obstructive pulmonary disease	0.000245	0.0081	CbGeAlD
Quetiapine—HRH1—lung—chronic obstructive pulmonary disease	0.000237	0.00786	CbGeAlD
Quetiapine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000233	0.00772	CbGeAlD
Quetiapine—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000232	0.0488	CrCbGaD
Quetiapine—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000214	0.0451	CrCbGaD
Quetiapine—Olanzapine—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.0425	CrCbGaD
Quetiapine—HTR2A—lung—chronic obstructive pulmonary disease	0.000198	0.00656	CbGeAlD
Quetiapine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0385	CrCbGaD
Quetiapine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0385	CrCbGaD
Quetiapine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000181	0.00599	CbGeAlD
Quetiapine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000179	0.0377	CrCbGaD
Quetiapine—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000178	0.0375	CrCbGaD
Quetiapine—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000177	0.0372	CrCbGaD
Quetiapine—Olanzapine—HTR2A—chronic obstructive pulmonary disease	0.000171	0.0359	CrCbGaD
Quetiapine—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000165	0.0347	CrCbGaD
Quetiapine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.0333	CrCbGaD
Quetiapine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000157	0.033	CrCbGaD
Quetiapine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000154	0.0325	CrCbGaD
Quetiapine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000154	0.0325	CrCbGaD
Quetiapine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000713	CcSEcCtD
Quetiapine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000713	CcSEcCtD
Quetiapine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000712	CcSEcCtD
Quetiapine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000712	CcSEcCtD
Quetiapine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000709	CcSEcCtD
Quetiapine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000709	CcSEcCtD
Quetiapine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000707	CcSEcCtD
Quetiapine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000707	CcSEcCtD
Quetiapine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000706	CcSEcCtD
Quetiapine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000138	0.029	CrCbGaD
Quetiapine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000138	0.000706	CcSEcCtD
Quetiapine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.000706	CcSEcCtD
Quetiapine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.000703	CcSEcCtD
Quetiapine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.0007	CcSEcCtD
Quetiapine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000699	CcSEcCtD
Quetiapine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000698	CcSEcCtD
Quetiapine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000697	CcSEcCtD
Quetiapine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000697	CcSEcCtD
Quetiapine—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000136	0.0286	CrCbGaD
Quetiapine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000135	0.000691	CcSEcCtD
Quetiapine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000689	CcSEcCtD
Quetiapine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000686	CcSEcCtD
Quetiapine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.000133	0.0281	CrCbGaD
Quetiapine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000682	CcSEcCtD
Quetiapine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000679	CcSEcCtD
Quetiapine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000679	CcSEcCtD
Quetiapine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000678	CcSEcCtD
Quetiapine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.000675	CcSEcCtD
Quetiapine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000675	CcSEcCtD
Quetiapine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000673	CcSEcCtD
Quetiapine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000672	CcSEcCtD
Quetiapine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00067	CcSEcCtD
Quetiapine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000669	CcSEcCtD
Quetiapine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000666	CcSEcCtD
Quetiapine—ABCB1—lung—chronic obstructive pulmonary disease	0.00013	0.0043	CbGeAlD
Quetiapine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.000663	CcSEcCtD
Quetiapine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000663	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000662	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000662	CcSEcCtD
Quetiapine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000657	CcSEcCtD
Quetiapine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000657	CcSEcCtD
Quetiapine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000654	CcSEcCtD
Quetiapine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000653	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000648	CcSEcCtD
Quetiapine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000648	CcSEcCtD
Quetiapine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000648	CcSEcCtD
Quetiapine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.0266	CrCbGaD
Quetiapine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000646	CcSEcCtD
Quetiapine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000646	CcSEcCtD
Quetiapine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000644	CcSEcCtD
Quetiapine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000642	CcSEcCtD
Quetiapine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000641	CcSEcCtD
Quetiapine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.0263	CrCbGaD
Quetiapine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00064	CcSEcCtD
Quetiapine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00064	CcSEcCtD
Quetiapine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000639	CcSEcCtD
Quetiapine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.000637	CcSEcCtD
Quetiapine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000633	CcSEcCtD
Quetiapine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000633	CcSEcCtD
Quetiapine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.000631	CcSEcCtD
Quetiapine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00063	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000627	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000627	CcSEcCtD
Quetiapine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000627	CcSEcCtD
Quetiapine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000626	CcSEcCtD
Quetiapine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000626	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000625	CcSEcCtD
Quetiapine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000621	CcSEcCtD
Quetiapine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000621	CcSEcCtD
Quetiapine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000621	CcSEcCtD
Quetiapine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000621	CcSEcCtD
Quetiapine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000621	CcSEcCtD
Quetiapine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000619	CcSEcCtD
Quetiapine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000619	CcSEcCtD
Quetiapine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000616	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000614	CcSEcCtD
Quetiapine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000614	CcSEcCtD
Quetiapine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000612	CcSEcCtD
Quetiapine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00061	CcSEcCtD
Quetiapine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000609	CcSEcCtD
Quetiapine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.000607	CcSEcCtD
Quetiapine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000604	CcSEcCtD
Quetiapine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000602	CcSEcCtD
Quetiapine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.000601	CcSEcCtD
Quetiapine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.0006	CcSEcCtD
Quetiapine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000599	CcSEcCtD
Quetiapine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000599	CcSEcCtD
Quetiapine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.000598	CcSEcCtD
Quetiapine—Olanzapine—ALB—chronic obstructive pulmonary disease	0.000117	0.0246	CrCbGaD
Quetiapine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000596	CcSEcCtD
Quetiapine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.000595	CcSEcCtD
Quetiapine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000594	CcSEcCtD
Quetiapine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000594	CcSEcCtD
Quetiapine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000594	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000592	CcSEcCtD
Quetiapine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000592	CcSEcCtD
Quetiapine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000587	CcSEcCtD
Quetiapine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000587	CcSEcCtD
Quetiapine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000582	CcSEcCtD
Quetiapine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000582	CcSEcCtD
Quetiapine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.0237	CrCbGaD
Quetiapine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000574	CcSEcCtD
Quetiapine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000574	CcSEcCtD
Quetiapine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000574	CcSEcCtD
Quetiapine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000574	CcSEcCtD
Quetiapine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000573	CcSEcCtD
Quetiapine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.000572	CcSEcCtD
Quetiapine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000568	CcSEcCtD
Quetiapine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000568	CcSEcCtD
Quetiapine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000567	CcSEcCtD
Quetiapine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000567	CcSEcCtD
Quetiapine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000565	CcSEcCtD
Quetiapine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.000564	CcSEcCtD
Quetiapine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000564	CcSEcCtD
Quetiapine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000563	CcSEcCtD
Quetiapine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000563	CcSEcCtD
Quetiapine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000562	CcSEcCtD
Quetiapine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000561	CcSEcCtD
Quetiapine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.023	CrCbGaD
Quetiapine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000557	CcSEcCtD
Quetiapine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000555	CcSEcCtD
Quetiapine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000554	CcSEcCtD
Quetiapine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000553	CcSEcCtD
Quetiapine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000551	CcSEcCtD
Quetiapine—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000107	0.0226	CrCbGaD
Quetiapine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000107	0.0225	CrCbGaD
Quetiapine—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000106	0.0223	CrCbGaD
Quetiapine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000542	CcSEcCtD
Quetiapine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000542	CcSEcCtD
Quetiapine—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000106	0.0222	CrCbGaD
Quetiapine—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000106	0.0222	CrCbGaD
Quetiapine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000106	0.0222	CrCbGaD
Quetiapine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.0222	CrCbGaD
Quetiapine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000535	CcSEcCtD
Quetiapine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000535	CcSEcCtD
Quetiapine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000535	CcSEcCtD
Quetiapine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000534	CcSEcCtD
Quetiapine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000533	CcSEcCtD
Quetiapine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00053	CcSEcCtD
Quetiapine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000524	CcSEcCtD
Quetiapine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000521	CcSEcCtD
Quetiapine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000521	CcSEcCtD
Quetiapine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000514	CcSEcCtD
Quetiapine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000514	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000513	CcSEcCtD
Quetiapine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000513	CcSEcCtD
Quetiapine—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.98e-05	0.000511	CcSEcCtD
Quetiapine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000506	CcSEcCtD
Quetiapine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.88e-05	0.000506	CcSEcCtD
Quetiapine—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.84e-05	0.000504	CcSEcCtD
Quetiapine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.71e-05	0.000497	CcSEcCtD
Quetiapine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.71e-05	0.000497	CcSEcCtD
Quetiapine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000493	CcSEcCtD
Quetiapine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.62e-05	0.000492	CcSEcCtD
Quetiapine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.51e-05	0.000487	CcSEcCtD
Quetiapine—Promazine—HTR2A—chronic obstructive pulmonary disease	9.51e-05	0.02	CrCbGaD
Quetiapine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.48e-05	0.000485	CcSEcCtD
Quetiapine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.39e-05	0.000481	CcSEcCtD
Quetiapine—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.39e-05	0.000481	CcSEcCtD
Quetiapine—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.19e-05	0.000471	CcSEcCtD
Quetiapine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.00047	CcSEcCtD
Quetiapine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.17e-05	0.000469	CcSEcCtD
Quetiapine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000463	CcSEcCtD
Quetiapine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000462	CcSEcCtD
Quetiapine—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000462	CcSEcCtD
Quetiapine—Rash—Formoterol—chronic obstructive pulmonary disease	8.95e-05	0.000458	CcSEcCtD
Quetiapine—Rash—Arformoterol—chronic obstructive pulmonary disease	8.95e-05	0.000458	CcSEcCtD
Quetiapine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.94e-05	0.000458	CcSEcCtD
Quetiapine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.94e-05	0.000458	CcSEcCtD
Quetiapine—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000458	CcSEcCtD
Quetiapine—Clozapine—HTR2A—chronic obstructive pulmonary disease	8.9e-05	0.0187	CrCbGaD
Quetiapine—Headache—Arformoterol—chronic obstructive pulmonary disease	8.89e-05	0.000455	CcSEcCtD
Quetiapine—Headache—Formoterol—chronic obstructive pulmonary disease	8.89e-05	0.000455	CcSEcCtD
Quetiapine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000455	CcSEcCtD
Quetiapine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.000454	CcSEcCtD
Quetiapine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.86e-05	0.000454	CcSEcCtD
Quetiapine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000454	CcSEcCtD
Quetiapine—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000453	CcSEcCtD
Quetiapine—Rash—Montelukast—chronic obstructive pulmonary disease	8.77e-05	0.000449	CcSEcCtD
Quetiapine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.76e-05	0.000448	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.000447	CcSEcCtD
Quetiapine—Depression—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.000447	CcSEcCtD
Quetiapine—Headache—Montelukast—chronic obstructive pulmonary disease	8.71e-05	0.000446	CcSEcCtD
Quetiapine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000441	CcSEcCtD
Quetiapine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.52e-05	0.000436	CcSEcCtD
Quetiapine—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000435	CcSEcCtD
Quetiapine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.46e-05	0.000433	CcSEcCtD
Quetiapine—Rash—Salbutamol—chronic obstructive pulmonary disease	8.45e-05	0.000433	CcSEcCtD
Quetiapine—Syncope—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000432	CcSEcCtD
Quetiapine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.44e-05	0.000432	CcSEcCtD
Quetiapine—Nausea—Formoterol—chronic obstructive pulmonary disease	8.43e-05	0.000432	CcSEcCtD
Quetiapine—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.43e-05	0.000432	CcSEcCtD
Quetiapine—Headache—Salbutamol—chronic obstructive pulmonary disease	8.4e-05	0.00043	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000424	CcSEcCtD
Quetiapine—Nausea—Montelukast—chronic obstructive pulmonary disease	8.26e-05	0.000423	CcSEcCtD
Quetiapine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000418	CcSEcCtD
Quetiapine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.13e-05	0.000416	CcSEcCtD
Quetiapine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8e-05	0.00041	CcSEcCtD
Quetiapine—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.96e-05	0.000408	CcSEcCtD
Quetiapine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.92e-05	0.000406	CcSEcCtD
Quetiapine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000405	CcSEcCtD
Quetiapine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000403	CcSEcCtD
Quetiapine—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.0004	CcSEcCtD
Quetiapine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000396	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	7.69e-05	0.000394	CcSEcCtD
Quetiapine—Shock—Prednisolone—chronic obstructive pulmonary disease	7.56e-05	0.000387	CcSEcCtD
Quetiapine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.5e-05	0.000384	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.43e-05	0.00038	CcSEcCtD
Quetiapine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000376	CcSEcCtD
Quetiapine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000365	CcSEcCtD
Quetiapine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000364	CcSEcCtD
Quetiapine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.95e-05	0.000356	CcSEcCtD
Quetiapine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.9e-05	0.000353	CcSEcCtD
Quetiapine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.000353	CcSEcCtD
Quetiapine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.00035	CcSEcCtD
Quetiapine—Pain—Prednisolone—chronic obstructive pulmonary disease	6.57e-05	0.000337	CcSEcCtD
Quetiapine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.00033	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000325	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.33e-05	0.000324	CcSEcCtD
Quetiapine—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000324	CcSEcCtD
Quetiapine—Agitation—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000322	CcSEcCtD
Quetiapine—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.00032	CcSEcCtD
Quetiapine—Malaise—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000316	CcSEcCtD
Quetiapine—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000315	CcSEcCtD
Quetiapine—Syncope—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000314	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000308	CcSEcCtD
Quetiapine—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000304	CcSEcCtD
Quetiapine—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.91e-05	0.000303	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000298	CcSEcCtD
Quetiapine—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000298	CcSEcCtD
Quetiapine—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000297	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000296	CcSEcCtD
Quetiapine—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000295	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.00029	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000286	CcSEcCtD
Quetiapine—Infection—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000284	CcSEcCtD
Quetiapine—Shock—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000281	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.00028	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000279	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000278	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000276	CcSEcCtD
Quetiapine—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000273	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000261	CcSEcCtD
Quetiapine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.08e-05	0.00026	CcSEcCtD
Quetiapine—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000259	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000257	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000252	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000249	CcSEcCtD
Quetiapine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.85e-05	0.000248	CcSEcCtD
Quetiapine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.84e-05	0.000248	CcSEcCtD
Quetiapine—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000247	CcSEcCtD
Quetiapine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.82e-05	0.000247	CcSEcCtD
Quetiapine—Constipation—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000245	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000236	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000234	CcSEcCtD
Quetiapine—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.57e-05	0.000234	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000226	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000226	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.12e-05	0.000211	CcSEcCtD
Quetiapine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.01e-05	0.000205	CcSEcCtD
Quetiapine—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000202	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000196	CcSEcCtD
Quetiapine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.69e-05	0.000189	CcSEcCtD
Quetiapine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000182	CcSEcCtD
Quetiapine—Rash—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.00018	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.00018	CcSEcCtD
Quetiapine—Headache—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000179	CcSEcCtD
Quetiapine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.00017	CcSEcCtD
Quetiapine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.32e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.32e-06	5.58e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.22e-06	5.48e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.17e-06	5.43e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.15e-06	5.4e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.14e-06	5.39e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.11e-06	5.37e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.11e-06	5.36e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.1e-06	5.36e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.1e-06	5.36e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.1e-06	5.35e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.09e-06	5.35e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.07e-06	5.33e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.07e-06	5.32e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.07e-06	5.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	5.05e-06	5.3e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.03e-06	5.28e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.01e-06	5.26e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.97e-06	5.22e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.96e-06	5.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.95e-06	5.19e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.94e-06	5.18e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.93e-06	5.17e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.91e-06	5.16e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.89e-06	5.13e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.88e-06	5.13e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.86e-06	5.11e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.85e-06	5.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.83e-06	5.07e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.83e-06	5.07e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.82e-06	5.06e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.81e-06	5.05e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.8e-06	5.04e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.8e-06	5.04e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.78e-06	5.02e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.75e-06	4.99e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.71e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.71e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.7e-06	4.94e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.69e-06	4.92e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.68e-06	4.92e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.64e-06	4.88e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	4.63e-06	4.86e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.62e-06	4.85e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.62e-06	4.85e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.59e-06	4.82e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.58e-06	4.81e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.56e-06	4.79e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.56e-06	4.79e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.56e-06	4.79e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.55e-06	4.78e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.54e-06	4.77e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.49e-06	4.72e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.49e-06	4.71e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.47e-06	4.69e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.46e-06	4.68e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.46e-06	4.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.45e-06	4.67e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.44e-06	4.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.43e-06	4.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	4.65e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.4e-06	4.62e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.39e-06	4.61e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.39e-06	4.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.38e-06	4.59e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.34e-06	4.56e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.34e-06	4.56e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-06	4.55e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.33e-06	4.55e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.33e-06	4.55e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.33e-06	4.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.27e-06	4.48e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.26e-06	4.47e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.24e-06	4.46e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.24e-06	4.45e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.23e-06	4.44e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.21e-06	4.42e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.21e-06	4.42e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.19e-06	4.4e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.18e-06	4.39e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.18e-06	4.39e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.18e-06	4.38e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.16e-06	4.37e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.14e-06	4.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.14e-06	4.35e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.13e-06	4.33e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.12e-06	4.33e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.12e-06	4.32e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.11e-06	4.32e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.1e-06	4.3e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.09e-06	4.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.07e-06	4.28e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.07e-06	4.27e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.06e-06	4.27e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.06e-06	4.26e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.05e-06	4.25e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.05e-06	4.25e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.04e-06	4.24e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.03e-06	4.23e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.01e-06	4.21e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4e-06	4.2e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-06	4.19e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.99e-06	4.19e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.98e-06	4.18e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.98e-06	4.17e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.97e-06	4.17e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.96e-06	4.15e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.95e-06	4.15e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.95e-06	4.14e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.92e-06	4.11e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.9e-06	4.09e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.9e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.89e-06	4.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.88e-06	4.07e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.85e-06	4.04e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.8e-06	3.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.79e-06	3.98e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.78e-06	3.97e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.76e-06	3.95e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.73e-06	3.92e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.7e-06	3.89e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.67e-06	3.85e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.66e-06	3.84e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.62e-06	3.81e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.61e-06	3.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.6e-06	3.78e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.6e-06	3.78e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.59e-06	3.77e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.58e-06	3.76e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.58e-06	3.75e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.58e-06	3.75e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.55e-06	3.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.55e-06	3.72e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.54e-06	3.71e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.52e-06	3.69e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.51e-06	3.68e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.51e-06	3.68e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.49e-06	3.67e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.47e-06	3.64e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.46e-06	3.64e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.44e-06	3.61e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.43e-06	3.61e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.43e-06	3.6e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.42e-06	3.59e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.41e-06	3.58e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.4e-06	3.57e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.38e-06	3.55e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.37e-06	3.54e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.37e-06	3.54e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.36e-06	3.53e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.33e-06	3.5e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.32e-06	3.49e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.31e-06	3.48e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-06	3.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.29e-06	3.45e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.29e-06	3.45e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.28e-06	3.45e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.27e-06	3.43e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.27e-06	3.43e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.26e-06	3.42e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.25e-06	3.41e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.24e-06	3.4e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.23e-06	3.4e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.23e-06	3.39e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.21e-06	3.37e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-06	3.36e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.2e-06	3.36e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.17e-06	3.33e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.17e-06	3.33e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.17e-06	3.32e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.15e-06	3.31e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.14e-06	3.3e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.13e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.12e-06	3.28e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.12e-06	3.27e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.1e-06	3.26e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.08e-06	3.24e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-06	3.22e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.06e-06	3.22e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.06e-06	3.21e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.04e-06	3.19e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.03e-06	3.19e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.02e-06	3.17e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.02e-06	3.17e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.99e-06	3.14e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.98e-06	3.13e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.98e-06	3.13e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.97e-06	3.12e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.97e-06	3.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.96e-06	3.1e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.94e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.94e-06	3.09e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.93e-06	3.08e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.93e-06	3.07e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.92e-06	3.06e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.91e-06	3.06e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.91e-06	3.05e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.9e-06	3.05e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.89e-06	3.03e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.88e-06	3.02e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.87e-06	3.02e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.87e-06	3.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.74e-06	2.87e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.73e-06	2.87e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-06	2.83e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-06	2.83e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.69e-06	2.83e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.69e-06	2.82e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.68e-06	2.82e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.68e-06	2.81e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.67e-06	2.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.67e-06	2.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.66e-06	2.79e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.64e-06	2.78e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.64e-06	2.77e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.64e-06	2.77e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.63e-06	2.77e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.63e-06	2.76e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.62e-06	2.75e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.59e-06	2.72e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.59e-06	2.71e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.57e-06	2.69e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.55e-06	2.68e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.48e-06	2.61e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.45e-06	2.57e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.44e-06	2.57e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.43e-06	2.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.4e-06	2.52e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.35e-06	2.47e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.34e-06	2.45e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.27e-06	2.39e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.25e-06	2.37e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.24e-06	2.35e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.22e-06	2.33e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.21e-06	2.32e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.2e-06	2.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.2e-06	2.31e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.18e-06	2.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.17e-06	2.28e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.06e-06	2.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.03e-06	2.13e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.02e-06	2.13e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.02e-06	2.12e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.02e-06	2.12e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.01e-06	2.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.99e-06	2.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.99e-06	2.09e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.97e-06	2.07e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-06	1.98e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.85e-06	1.94e-05	CbGpPWpGaD
